Login

Aarey Drugs & Pharmaceuticals Ltd.

₹71.0

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Aarey Drugs & Pharmaceuticals Ltd.

  • NSE : AAREYDRUGS

₹71.0

₹71.0

-0.59 (-0.82%) - 12 Jul 2025 04:28 PM
  • NSE : AAREYDRUGS

About Company

Aarey Drugs & Pharmaceuticals Ltd.is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The Therapeutic targets of the company's products are Allergy, Dermatology & Infectious Diseases

Market Cap. ₹ 201 Cr.
52 Week - High/Low ₹ 75/31
P/E Ratio 49.31
P/B Ratio 1.52
Enterprise Value ₹ 203 Cr.
ROE % 3.82
RSI Value 77.68
EMA 50 59.46
EMA 200 53.9
Market Cap. ₹ 201 Cr.
52 Week - High/Low ₹ 75/31
P/E Ratio N/A
P/B Ratio N/A
Enterprise Value -
ROE % N/A
RSI Value 77.68
EMA 50 59.46
EMA 200 53.9
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.